Showing results (51-60 of 872) with videos related to

Sort By:
Pageof 88
Therapeutic Advances in Gastroenterology|November 17, 2025
JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel diseaseFotios S Fousekis, André Jefremow, Konstantinos H Katsanos, et al.
Digestion|August 21, 2014
Prospective long-term assessment of sedation-related adverse events and patient satisfaction for upper endoscopy and colonoscopyBeate Kilgert, Lydia Rybizki, Michael Grottke, et al.
World Journal of Gastroenterology|September 14, 2011
Cancer risk in IBD: how to diagnose and how to manage DALM and ALMHelmut Neumann, Michael Vieth, Cord Langner, et al.
Current Research in Pharmacology and Drug Discovery|March 29, 2022
Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy?Raja Atreya, Christian Bojarski, Anja A Kühl, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 19, 2018
Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot studyRuediger S Goertz, Daniel Klett, Dane Wildner, et al.
World Journal of Gastroenterology|January 10, 2015
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesGian Eugenio Tontini, Maurizio Vecchi, Luca Pastorelli, et al.
Frontiers in Immunology|August 23, 2018
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel DiseasesTimo Rath, Ulrike Billmeier, Fulvia Ferrazzi, et al.
Frontiers in Medicine|August 9, 2021
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular EndoscopyChristian Bojarski, Maximilian Waldner, Timo Rath, et al.
Frontiers in Immunology|May 1, 2026
Case Report: Successful anti-TNF antibody therapy in steroid-dependent segmental colitis associated with diverticulosis and concomitant ulcerative colitisFotios Fousekis, Jürgen Siebler, Timo Rath, et al.
Crohn'S & Colitis 360|August 11, 2020
Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD PatientsMatthias Breidert, Pierre Eftekhari, François Louis, et al.
Pageof 88